Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography

Olaf van Tellingen(Dutch Cancer Society), A. Bult, Jos H. Beijnen(The Netherlands Cancer Institute), Anneloes L. C. Sonneveldt(The Netherlands Cancer Institute), Cornelis Versluis(Utrecht University), J. J. Kettenes‐van den Bosch, Willem J. Nooijen(The Netherlands Cancer Institute)
Cancer Chemotherapy and Pharmacology
September 1, 1994
10.1007/bf00686273
Cited by 8

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688